Page 29 - Gamida Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gamida Cell (NASDAQ:GMDA – Get Rating) and Codiak BioSciences (NASDAQ:CDAK – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability. Insider and Institutional Ownership 53.4% of Gamida Cell shares […]

/PRNewswire/ -- DelveInsight's Chemotherapy Induced Anemia Market Insights report provides a comprehensive understanding of current treatment practices,...

The Chemotherapy Induced Anemia market is expected to grow owing to the disease awareness and the emergence of new products in the pipeline. In addition, persistently rising cases of Chemotherapy

Gamida Cell (NASDAQ:GMDA – Get Rating) and Entera Bio (NASDAQ:ENTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations. Profitability This table compares Gamida Cell and Entera Bio’s […]

AlloVir Appoints Shawn Tomasello to Its Board of Directors - read this article along with other careers information, tips and advice on BioSpace